DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021" report to their offering.
The global membrane filtration market for pharmaceutical is expected to reach USD 6.20 Billion by 2021 from USD 3.55 Billion in 2016, at a CAGR of 11.8% during the forecast period.
Growth in the biopharmaceutical industry and advancements in the nanofiltration technology are the key factors driving the growth of the market.
The global membrane filtration market for pharmaceutical has been segmented on the basis of product, technique, application, and region. On the basis of product, the global market is segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters. The MCE membrane filters segment is expected to be the largest and fastest-growing segment of the global market in 2016.
On the basis of application, the market is segmented into final product processing, raw material filtration, air purification, cell separation, and water purification. The final product processing segment is projected to grow at the highest CAGR during the forecast period. Rapid growth in the biopharmaceutical industry, expansion in generic production, increasing demand for nanofiber technology, and the rising prevalence of airborne diseases are the major factors driving the growth of this segment.
On the basis of technique, the market segmented into microfiltration, crossfiltration, ultrafiltration, nanofiltration, ion exchange, and reverse osmosis. The microfiltration segment is expected to witness the highest CAGR during the forecast period. The high adoption of microfiltration over other techniques in pharmaceutical applications accounts for the large share of this segment.
North America is expected to dominate the global membrane filtration market for pharmaceutical in 2016, owing to the increasing growth in the biopharmaceutical industry in North America. However, the Asia region is expected to witness the highest CAGR during the forecast period. The increasing incidence of airborne diseases, growing R&D spending by developed countries, and rapid expansion in generic drug production are the major drivers for the growth of the Asian market.
- Growth in the Biopharmaceutical Industry
- Advancements in the Nanofiltration Technology
- Growing Application in the Control of Airborne Diseases
- Significant Rise in Generic Drug Production
- Strong Biologics Pipeline
- Strict Government Regulations for Validation of the Filtration Process
- Low Adoption of Membrane Filters in Emerging Markets Due to Cost Constraints
- Growth Potential in Emerging Markets
- Intense Competition in the Market is A Critical Entry Barrier for New Entrants
- Rising Adoption of Single-Use Technologies
- 3M Company
- ALFA Laval
- Danaher Corporation (Pall Corporation)
- GEA Group
- General Electric Company
- Graver Technologies, LLC
- Koch Membrane System
- Merck KGaA
- Sartorius Stedim Biotech S.A.
For more information about this report visit http://www.researchandmarkets.com/research/gdvf9s/pharmaceutical